中文 | English
Return
Total: 1 , 1/1
Show Home Prev Next End page: GO
Author:(Miaoxin PENG)

1.Ruxolitinib combined with venetoclax and azacitidine in the treatment of refractory T-ALL patients with JAK1, JAK3, and STAT5B gene mutations: a case report and literature review

Peipei XU ; Tong ZHOU ; Yueyi XU ; Miaoxin PENG ; Ying DU ; Ting XIE ; Yonggong YANG ; Jian OUYANG ; Bing CHEN

Chinese Journal of Hematology 2024;45(9):872-875

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1 , 1/1 Show Home Prev Next End page: GO